XML 47 R20.htm IDEA: XBRL DOCUMENT

Subsequent Events	12 Months Ended
Subsequent Events	Dec. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 14 – Subsequent Events On January 5, 2023, the Company granted an option to purchase 1,124,600 shares of common stock to the management and employees of the Company with a strike price of $11.61 vesting 25% on the first anniversary and the remaining vesting in equal monthly installments thereafter until fully vested. Included in the above mentioned grant, the Company granted an option to purchase 385,300, 137,200 and 161,200 to its Chief Executive Officer, Chief Scientific Officer and its Chief Medical Officer, respectively. In the first quarter of 2023, the Company sold 553,293 shares of common stock for a value of $4.6 million pursuant to its Sales Agreement.